{
 "drug": "Itraconazole Capsule",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "02/27/2026",
 "dayN": 179,
 "cat": "Anti-Infective",
 "companies": [
  "Janssen Pharmaceuticals"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "02/27/2026",
   "update_type": "New",
   "initial_posting_date": "02/27/2026",
   "package_ndc": "50458-290-04",
   "generic_name": "Itraconazole Capsule",
   "contact_info": "800-JANSSEN (1-800-526-7736)",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020083"
    ],
    "brand_name": [
     "SPORANOX"
    ],
    "generic_name": [
     "ITRACONAZOLE"
    ],
    "manufacturer_name": [
     "Janssen Pharmaceuticals, Inc."
    ],
    "product_ndc": [
     "50458-290"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ITRACONAZOLE"
    ],
    "rxcui": [
     "311204",
     "833164"
    ],
    "spl_id": [
     "a79c080b-711a-4a15-af92-ff0c60cbfdf1"
    ],
    "spl_set_id": [
     "a4d555fa-787c-40fb-bb7d-b0d4f7318fd0"
    ],
    "package_ndc": [
     "50458-290-01",
     "50458-290-04",
     "50458-290-28"
    ],
    "nui": [
     "N0000175487",
     "M0002083",
     "N0000182141",
     "N0000185503",
     "N0000190113"
    ],
    "pharm_class_epc": [
     "Azole Antifungal [EPC]"
    ],
    "pharm_class_cs": [
     "Azoles [CS]"
    ],
    "pharm_class_moa": [
     "Cytochrome P450 3A4 Inhibitors [MoA]",
     "P-Glycoprotein Inhibitors [MoA]",
     "Breast Cancer Resistance Protein Inhibitors [MoA]"
    ],
    "unii": [
     "304NUG5GF4"
    ]
   },
   "update_date": "02/27/2026",
   "therapeutic_category": [
    "Anti-Infective",
    "Other"
   ],
   "dosage_form": "Capsule",
   "presentation": "Sporanox, Capsule, 100 mg (NDC 50458-290-04)",
   "company_name": "Janssen Pharmaceuticals",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "02/27/2026",
   "update_type": "New",
   "initial_posting_date": "02/27/2026",
   "package_ndc": "50458-290-01",
   "generic_name": "Itraconazole Capsule",
   "contact_info": "800-JANSSEN (1-800-526-7736)",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020083"
    ],
    "brand_name": [
     "SPORANOX"
    ],
    "generic_name": [
     "ITRACONAZOLE"
    ],
    "manufacturer_name": [
     "Janssen Pharmaceuticals, Inc."
    ],
    "product_ndc": [
     "50458-290"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ITRACONAZOLE"
    ],
    "rxcui": [
     "311204",
     "833164"
    ],
    "spl_id": [
     "a79c080b-711a-4a15-af92-ff0c60cbfdf1"
    ],
    "spl_set_id": [
     "a4d555fa-787c-40fb-bb7d-b0d4f7318fd0"
    ],
    "package_ndc": [
     "50458-290-01",
     "50458-290-04",
     "50458-290-28"
    ],
    "nui": [
     "N0000175487",
     "M0002083",
     "N0000182141",
     "N0000185503",
     "N0000190113"
    ],
    "pharm_class_epc": [
     "Azole Antifungal [EPC]"
    ],
    "pharm_class_cs": [
     "Azoles [CS]"
    ],
    "pharm_class_moa": [
     "Cytochrome P450 3A4 Inhibitors [MoA]",
     "P-Glycoprotein Inhibitors [MoA]",
     "Breast Cancer Resistance Protein Inhibitors [MoA]"
    ],
    "unii": [
     "304NUG5GF4"
    ]
   },
   "update_date": "02/27/2026",
   "therapeutic_category": [
    "Anti-Infective",
    "Other"
   ],
   "dosage_form": "Capsule",
   "presentation": "Sporanox, Capsule, 100 mg (NDC 50458-290-01)",
   "company_name": "Janssen Pharmaceuticals",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "02/27/2026",
   "update_type": "New",
   "initial_posting_date": "02/27/2026",
   "package_ndc": "10147-1700-3",
   "generic_name": "Itraconazole Capsule",
   "contact_info": "800-JANSSEN (1-800-526-7736)",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020083"
    ],
    "brand_name": [
     "ITRACONAZOLE"
    ],
    "generic_name": [
     "ITRACONAZOLE"
    ],
    "manufacturer_name": [
     "Patriot Pharmaceuticals"
    ],
    "product_ndc": [
     "10147-1700"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ITRACONAZOLE"
    ],
    "rxcui": [
     "311204"
    ],
    "spl_id": [
     "2cca3625-96e8-34cf-e063-6294a90ac975"
    ],
    "spl_set_id": [
     "6242b7ad-eaa0-a524-b6e0-ec33e63407db"
    ],
    "package_ndc": [
     "10147-1700-3",
     "10147-1700-7"
    ],
    "nui": [
     "N0000175487",
     "M0002083",
     "N0000182141",
     "N0000185503",
     "N0000190113"
    ],
    "pharm_class_epc": [
     "Azole Antifungal [EPC]"
    ],
    "pharm_class_cs": [
     "Azoles [CS]"
    ],
    "pharm_class_moa": [
     "Cytochrome P450 3A4 Inhibitors [MoA]",
     "P-Glycoprotein Inhibitors [MoA]",
     "Breast Cancer Resistance Protein Inhibitors [MoA]"
    ],
    "unii": [
     "304NUG5GF4"
    ]
   },
   "update_date": "02/27/2026",
   "therapeutic_category": [
    "Anti-Infective",
    "Other"
   ],
   "dosage_form": "Capsule",
   "presentation": "Sporanox, Capsule, 100 mg (NDC 10147-1700-3)",
   "company_name": "Janssen Pharmaceuticals",
   "status": "To Be Discontinued"
  }
 ]
}